A forty-four-patient randomized trial found improved sedation-target measures with the combination. Its observation period did not include later withdrawal or dependence outcomes.
The measured benefit
Twenty-two children per group received midazolam alone or midazolam with fentanyl. Infusions were adjusted using the Comfort Behavior Scale relative to a target score.
The combination group spent less recorded time substantially above the target, indicating less rated undersedation, and received less midazolam. Two hypotensive events occurred in each group under the reported monitoring.
What the trial could not establish
A lower midazolam total alongside an added opioid is not necessarily a lower overall sedative or respiratory burden. Different pharmacologic effects contribute to the same behavioral target.
The authors noted uneven observation because many participants left the study before forty-eight hours. The small sample could not establish uncommon-event safety, and assessment stopped with the study drugs rather than covering subsequent withdrawal or dependence.
Use in a report
State the behavioral scale and exposure period. This trial supports a regimen-specific sedation result, not a guarantee that the combination is safer for every ventilated child. Later agitation, respiratory events, or withdrawal require separate evaluation rather than inference from the absence of those endpoints in the trial.
Source paper
Original analysis of the supplied journal article, identified as PMC6335121.
Leave a Reply